Femasys Inc. has partnered with SandsRx Pharmacy to support the launch of its FemaSeed fertility treatment to OB/GYN practices. This collaboration aims to provide specialized pharmacy support, medication coordination, and preferred pricing to help integrate FemaSeed and related fertility products into OB/GYN care. FemaSeed enables first-line fertility treatment within OB/GYN offices, improving access and reducing costs by offering sperm placement directly where conception occurs. SandsRx will provide medication expertise and patient support to enhance treatment outcomes and confidence.
Femasys partnership news offers context for health sector investors. Of 150 US health stocks on Pluang, 81 rose and 62 fell today. Notable movers include CTXR at USD 0.45 (+5.19%) with 69% buy orders, XRAY at USD 8.84 (+4.99%), and ENVB at USD 1.34 (-4.96%) with 100% sell orders. Data is as of Oct 20, 2026 19:03 WIB.
RoyaLand Company Ltd. announced Palazzo Chronicles, a free-to-play mobile match-3 puzzle game set in 19th-century Piedmont during Italy's reunification. Players help Adelaide restore her inherited family castle by solving puzzles and rebuilding rooms...
Route 92 Medical has secured a $100 million senior secured debt facility from Trinity Capital to strengthen its balance sheet and support ongoing product innovation and commercial growth. The funding will help the company expand its neurovascular int...
First Federal Savings Bank marks its 122nd anniversary, highlighting over a century of service to Southwest Indiana and Western Kentucky. The bank has grown from a single community institution to ten locations, focusing on personal service, local dec...
Aclarion, Inc. announced an 85% year-over-year increase in scan volumes for Q3 2026, contributing to a 117% growth for the first nine months of the year. The company highlighted the publication of supportive clinical data in the European Spine Journa...
The global electric vehicle (EV) components market is projected to grow from $486.4 billion in 2026 to $1.28 trillion by 2036, expanding at a 10.2% CAGR. Growth is fueled by rising EV adoption, advancements in battery systems, power electronics, and ...
